Literature DB >> 36036128

Serum levels of degraded monosaccharides in children with Henoch-Schönlein purpura.

Zhi-Liang Wang1, Kai-Di Sheng, Yi Lin1, Qiu-Ye Zhang1, Li-Juan Zhang, Hong Chang1.   

Abstract

OBJECTIVES: To examine the serum levels of degraded monosaccharides in children with Henoch-Schönlein purpura (HSP) and to study the clinical significance of degraded monosaccharides in HSP.
METHODS: A prospective analysis was performed on 132 children who were diagnosed with HSP from September 2019 to January 2022, and 132 healthy children were enrolled as the control group. High-performance liquid chromatography was used to determine the content of degraded monosaccharides in serum in both groups. The receiver operating characteristic (ROC) curve was used to evaluate the efficiency of degraded monosaccharides for the diagnosis of HSP.
RESULTS: Compared with the control group, the HSP group had significantly higher serum levels of mannose, glucosamine, aminogalactose, and galactose (P<0.001). The four degraded monosaccharides had an area under the ROC curve of 0.919, 0.913, 0.832, and 0.932 respectively for the diagnosis of HSP (P<0.05).
CONCLUSIONS: Children with HSP have higher serum levels of mannose, glucosamine, aminogalactose, and galactose than the healthy population. The levels of degraded monosaccharides may have an important value for the diagnosis of HSP.

Entities:  

Keywords:  Child; Diagnosis; Henoch-Schönlein purpura; Monosaccharide

Mesh:

Substances:

Year:  2022        PMID: 36036128      PMCID: PMC9425874          DOI: 10.7499/j.issn.1008-8830.2202125

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  9 in total

Review 1.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

2.  [Clinical characteristics of Henoch-Schönlein purpura in children].

Authors:  Li-Jun Liu; Jing Yu; Yu-Ning Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2015-10

3.  [Evidence-based guideline for diagnosis and treatment of Henoch-Schonlein purpura nephritis (2016)].

Authors: 
Journal:  Zhonghua Er Ke Za Zhi       Date:  2017-09-02

4.  Using a PCR instrument to hydrolyze polysaccharides for monosaccharide composition analyses.

Authors:  Meng Zhang; Yiran Zhang; Xuexiao Ma; Xiangping Liu; Min Niu; Ruyong Yao; Lijuan Zhang
Journal:  Carbohydr Polym       Date:  2020-04-22       Impact factor: 9.381

5.  Evaluation of IgA1 O-glycosylation in Henoch-Schönlein Purpura Nephritis Using Mass Spectrometry.

Authors:  Shigeaki Nakazawa; Ryoichi Imamura; Masataka Kawamura; Taigo Kato; Toyofumi Abe; Hirotsugu Iwatani; Kazuaki Yamanaka; Motohide Uemura; Hidefumi Kishikawa; Kenji Nishimura; Michiko Tajiri; Yoshinao Wada; Norio Nonomura
Journal:  Transplant Proc       Date:  2019-05-10       Impact factor: 1.066

6.  [Endoscope-assisted parotidectomy for benign tumors via a short hidden auricular incision].

Authors:  Li Gao; Yan Shao; Lei Xie; Ying Hu; Hua Li; Xue-Hong Ye; Chun-Yi Song
Journal:  Zhonghua Zheng Xing Wai Ke Za Zhi       Date:  2004-07

Review 7.  Glycan-based biomarkers for diagnosis of cancers and other diseases: Past, present, and future.

Authors:  Minghui Hu; Ying Lan; Alexander Lu; Xuexiao Ma; Lijuan Zhang
Journal:  Prog Mol Biol Transl Sci       Date:  2019-03-06       Impact factor: 3.622

8.  [Value of galactose-deficient IgA1 in the early diagnosis of Henoch-Schönlein purpura nephritis in children].

Authors:  Zhi-Juan Kang; Bo Liu; Zhi-Hui Li; Cui-Rong Duan; Tian-Hui Wu; Man Xun; Yi Zhang; Yun-Feng Ding; Ru-Qian Fu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-02

Review 9.  Biological roles of glycans.

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2016-08-24       Impact factor: 4.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.